These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38175660)

  • 1. Initiating Immunotherapy in the Treatment of Stage IV Cancers in the Month Before Death-A Health Care Disparities Lens.
    Hoerger M; Nair N; Malhotra S
    JAMA Oncol; 2024 Mar; 10(3):297-299. PubMed ID: 38175660
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US.
    Kerekes DM; Frey AE; Prsic EH; Tran TT; Clune JE; Sznol M; Kluger HM; Forman HP; Becher RD; Olino KL; Khan SA
    JAMA Oncol; 2024 Mar; 10(3):342-351. PubMed ID: 38175659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaps Exist in End-of-Life Immunotherapy Treatment for Cancer.
    Harris E
    JAMA; 2024 Feb; 331(6):467. PubMed ID: 38265830
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune-Based Cancer Treatment: Addressing Disparities in Access and Outcomes.
    Osarogiagbon RU; Sineshaw HM; Unger JM; Acuña-Villaorduña A; Goel S
    Am Soc Clin Oncol Educ Book; 2021 Mar; 41():1-13. PubMed ID: 33830825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancing healthcare disparities research in patients with stage IV cancer.
    Obeng-Gyasi S
    Am J Surg; 2023 Jul; 226(1):19. PubMed ID: 37095042
    [No Abstract]   [Full Text] [Related]  

  • 6. Explaining disparities in oncology health systems delays and stage at diagnosis between men and women in Botswana: A cohort study.
    Iyer HS; Kohler RE; Ramogola-Masire D; Brown C; Molebatsi K; Grover S; Kablay I; Bvochora-Nsingo M; Efstathiou JA; Lockman S; Tapela N; Dryden-Peterson SL
    PLoS One; 2019; 14(6):e0218094. PubMed ID: 31170274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Socioeconomic disparities in immunotherapy use among advanced-stage non-small cell lung cancer patients: analysis of the National Cancer Database.
    Gupta A; Omeogu C; Islam JY; Joshi A; Zhang D; Braithwaite D; Karanth SD; Tailor TD; Clarke JM; Akinyemiju T
    Sci Rep; 2023 May; 13(1):8190. PubMed ID: 37210410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in the use of antineoplastic immunotherapy in pediatric malignant adrenal tumors.
    Shoag JM; Podda A; Kobetz EN
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28522. PubMed ID: 32614121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy Treatment Disparities: A Texas Cancer Registry Analysis of Patients with Cutaneous Melanoma.
    Ramirez F; Alvarado L; Dwivedi A; Chacon J
    J Immigr Minor Health; 2024 Feb; 26(1):23-33. PubMed ID: 37615821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer care and outcomes through a health equity lens.
    Barbour V
    Med J Aust; 2023 Nov; 219(9):397. PubMed ID: 37925644
    [No Abstract]   [Full Text] [Related]  

  • 11. Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United States.
    Ahn JC; Lauzon M; Luu M; Noureddin M; Ayoub W; Kuo A; Sundaram V; Kosari K; Nissen N; Gong J; Hendifar A; Roberts LR; Abou-Alfa GK; Singal AG; Yang JD
    Hepatology; 2022 Dec; 76(6):1649-1659. PubMed ID: 35429171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unequal racial distribution of immunotherapy for late-stage non-small cell lung cancer.
    Chang A; Flores RM; Taioli E
    J Natl Cancer Inst; 2023 Oct; 115(10):1224-1226. PubMed ID: 37421405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Disparities in Stage at Diagnosis, Treatment, and Survival in Nonelderly Adult Patients with Cancer According to Insurance Status.
    Penson DF
    J Urol; 2015 Aug; 194(2):501-2. PubMed ID: 26195419
    [No Abstract]   [Full Text] [Related]  

  • 14. Survival Disparities by Hospital Volume Among American Women With Gynecologic Cancers.
    Seagle BL; Strohl AE; Dandapani M; Nieves-Neira W; Shahabi S
    JCO Clin Cancer Inform; 2017 Nov; 1():1-15. PubMed ID: 30657373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research in cancer care disparities in countries with universal healthcare: mapping the field and its conceptual contours.
    Sinding C; Warren R; Fitzpatrick-Lewis D; Sussman J
    Support Care Cancer; 2014 Nov; 22(11):3101-20. PubMed ID: 25120008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated health systems and evidence-based care: standardizing treatment to eliminate cancer disparities.
    Patel MI; Rhoads KF
    Future Oncol; 2015; 11(12):1715-8. PubMed ID: 26075439
    [No Abstract]   [Full Text] [Related]  

  • 17. Disparities in Care Management During Terminal Hospitalization Among Adults With Metastatic Cancer From 2010 to 2017.
    Deeb S; Chino FL; Diamond LC; Tao A; Aragones A; Shahrokni A; Yerramilli D; Gillespie EF; Tsai CJ
    JAMA Netw Open; 2021 Sep; 4(9):e2125328. PubMed ID: 34550384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moonshot or groundshot: addressing Europe's cancer challenge through a patient-focused, data-enabled lens.
    Lawler M; Naredi P; Cufer T; Banks I; Lievens Y; Vassal G; Aapro M; Sotlar MJ; Philip T; Jassem J; Pelouchova J; Meunier F; Sullivan R;
    Lancet Oncol; 2019 Nov; 20(11):1482-1485. PubMed ID: 31674308
    [No Abstract]   [Full Text] [Related]  

  • 19. Racial disparities in end-of-life care.
    Kuschner WG
    Arch Intern Med; 2011 May; 171(10):949-50; author reply 950. PubMed ID: 21606104
    [No Abstract]   [Full Text] [Related]  

  • 20. Racial disparities in cancer care, an eyeopener for developing better global cancer management strategies.
    Bharmjeet ; Das A
    Cancer Rep (Hoboken); 2023 Sep; 6 Suppl 1(Suppl 1):e1807. PubMed ID: 36971312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.